Peptide record

TPDB18284

Antibacterial Toxicity modified_plain modified
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18284
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 13-aa modified multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
AXKAXWKXVKXVK
Physicochemical Analysis
C51H88N14O10
RNDCEQGHILMFPSTY
K
1057.35
11.00
4
0
5
+4
1.91
-0.346
60.00
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
5500
520.17
0
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
4
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 4 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 2
Chemical Descriptors
13
C51H88N14O10
1057.35
11.00
+4
1.91
-0.346
Evidence Records 2 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
5 µM
Hemolytic Cytotoxic
0% Hemolysis | 5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency. | Antimicrob Agents Chemother | 2011
Evidence 2 Activity

Activity

15% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
15% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency. | Antimicrob Agents Chemother | 2011